Login to Your Account


High-dose chemo helps cancer vaccine

By Anette Breindl
Senior Science Editor

Monday, April 17, 2017

A dendritic cell vaccine against a viral antigen induced long-term survival in three out of 11 treated glioblastoma patients, scientists reported in the April 15, 2017, issue of Clinical Cancer Research.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription